News
Applaud Medical Completes Series B Funding Round
October 28, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today confirmed that it had successfully…Applaud Medical selected by MedTech Innovator as one of Top 50 Medtech Startups
June 15, 2021 | News
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies…Applaud Medical Announces First Patient Enrolled in IDE Study
June 3, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced announced enrollment of the…Applaud Medical Granted New U.S. Patent for the Company’s Acoustic Enhancer Technology
March 23, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that a new U.S.…Applaud Medical Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study
September 8, 2020 | News
SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced it has received approval…
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision O, April 2025.